×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Incorporation and Acceptance of Real World Evidence in Market Access Discussions – Case Studies
Session Chair(s)
Niklas Hedberg, MPharm
HTACG Co-Chair & Chief Pharmacist
Dental and Pharmaceutical Benefits Agency, TLV, Sweden
The session has the aim to cover important and challenging issues around the concept of RWD. Who needs what? What will different stakeholder be prepared to use and trust when RWD is on the table?
Speaker(s)
Partnering to Enable Evidence Generation
David Myers
Janssen Pharmaceuticals, Sweden
Associate Director Market Access RWE Partnerships
What Do We Do with New Data Sets?
Evert Jan van Lente, MS
AOK Bundesverband (Federal Insurer), Germany
Director EU-Affairs
How Do Patients Want to be Approached to Contribute to a Better Environment for RWD? Do Patients Experience A Double Role, Sharing Their Own Data and Depending on the Decisions Based on Those Data?
Bettina Ryll
MPNE, Vision Zero Cancer, Sweden
Member of the First EU Cancer Mission Board
Have an account?